179 related articles for article (PubMed ID: 15658879)
1. Synthesis and enzyme-specific activation of carbohydrate-geldanamycin conjugates with potent anticancer activity.
Cheng H; Cao X; Xian M; Fang L; Cai TB; Ji JJ; Tunac JB; Sun D; Wang PG
J Med Chem; 2005 Jan; 48(2):645-52. PubMed ID: 15658879
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
4. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
[TBL] [Abstract][Full Text] [Related]
6. Iminosugars from Baphia nitida Lodd.
Kato A; Kato N; Miyauchi S; Minoshima Y; Adachi I; Ikeda K; Asano N; Watson AA; Nash RJ
Phytochemistry; 2008 Mar; 69(5):1261-5. PubMed ID: 18191969
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
Crèvecoeur J; Merville MP; Piette J; Gloire G
Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
[TBL] [Abstract][Full Text] [Related]
8. Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.
Fang L; Battisti RF; Cheng H; Reigan P; Xin Y; Shen J; Ross D; Chan KK; Martin EW; Wang PG; Sun D
J Med Chem; 2006 Oct; 49(21):6290-7. PubMed ID: 17034135
[TBL] [Abstract][Full Text] [Related]
9. Studies on quinones. Part 41: synthesis and cytotoxicity of isoquinoline-containing polycyclic quinones.
Valderrama JA; González MF; Pessoa-Mahana D; Tapia RA; Fillion H; Pautet F; Rodriguez JA; Theoduloz C; Schmeda-Hirschmann G
Bioorg Med Chem; 2006 Jul; 14(14):5003-11. PubMed ID: 16563773
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of chemotherapeutics by the Hsp90 antagonist geldanamycin requires a steady serum condition.
Burkitt M; Magee C; O'Connor D; Campbell F; Cornford P; Greenhalf W
Mol Carcinog; 2007 Jun; 46(6):466-75. PubMed ID: 17219417
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a broad specificity beta-glucosidase from sheep liver.
Chinchetru MA; Cabezas JA; Calvo P
Int J Biochem; 1989; 21(5):469-76. PubMed ID: 2503402
[TBL] [Abstract][Full Text] [Related]
13. Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.
Maroney AC; Marugan JJ; Mezzasalma TM; Barnakov AN; Garrabrant TA; Weaner LE; Jones WJ; Barnakova LA; Koblish HK; Todd MJ; Masucci JA; Deckman IC; Galemmo RA; Johnson DL
Biochemistry; 2006 May; 45(17):5678-85. PubMed ID: 16634649
[TBL] [Abstract][Full Text] [Related]
14. Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy.
Fang L; Sun D
Drug Metab Dispos; 2008 Jun; 36(6):1153-65. PubMed ID: 18356268
[TBL] [Abstract][Full Text] [Related]
15. Novel synthesis, cytotoxic evaluation, and structure-activity relationship studies of a series of alpha-alkylidene-gamma-lactones and lactams.
Janecki T; Błaszczyk E; Studzian K; Janecka A; Krajewska U; Rózalski M
J Med Chem; 2005 May; 48(10):3516-21. PubMed ID: 15887960
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of (+)-geldanamycin and (-)-o-quinogeldanamycin: asymmetric glycolate aldol reactions and biological evaluation.
Andrus MB; Meredith EL; Hicken EJ; Simmons BL; Glancey RR; Ma W
J Org Chem; 2003 Oct; 68(21):8162-9. PubMed ID: 14535799
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
[TBL] [Abstract][Full Text] [Related]
18. A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
Chen C; Shi Y; Li S; Qi Q; Gu L; Song J; Wang PG
Arch Pharm (Weinheim); 2006 Jul; 339(7):366-71. PubMed ID: 16783837
[TBL] [Abstract][Full Text] [Related]
19. A new kinetic model of recombinant beta-galactosidase from Kluyveromyces lactis for both hydrolysis and transgalactosylation reactions.
Kim CS; Ji ES; Oh DK
Biochem Biophys Res Commun; 2004 Apr; 316(3):738-43. PubMed ID: 15033461
[TBL] [Abstract][Full Text] [Related]
20. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
